ENOGLOBIN

Welcome to the Brand page for “ENOGLOBIN”, which is offered here for Pharmaceuticals, hemoglobin based pharmaceuticals for the treatment of hypotension and solid tumor cancers;.

Its status is currently believed to be active. Its class is unavailable. “ENOGLOBIN” is believed to be currently owned by “Apex Biosience, Inc.”

ENOGLOBIN differentiates itself from competing brands by offering hemoglobin-based pharmaceuticals specifically targeting hypotension and solid tumor cancers, distinguishing it from general pharmaceutical brands.ENOGLOBIN stands out for its specialized focus on utilizing hemoglobin for treating specific medical conditions effectively, demonstrating a unique and innovative approach in the pharmaceutical industry.

Owner:	APEX BIOSIENCE, INC. Owner Details
Description:	Pharmaceuticals, hemoglobin based pharmaceuticals for the treatment of hypotension and solid tumor cancers;
Categories:	PHARMACEUTICALS